Singer Capital Markets Securities Ltd, an exempt principal trader, disclosed dealings in HIPGNOSIS SONGS FUND LTD's securities on 2nd July 2024. The disclosed dealings involved the purchase of 705 ORD NVP (USD) securities at a price range of 1.26 per unit. The disclosure also confirmed that there were no cash-settled derivative transactions, stock-settled derivative transactions, or other dealings, including subscribing for new securities. Additionally, there were no indemnity or other dealing arrangements, agreements, arrangements, or understandings relating to options or derivatives.

The disclosure was made in accordance with Rule 8.5 of the Takeover Code and was submitted to the Regulatory Information Service on 3rd July 2024. For any further information or consultation regarding the Code's dealing disclosure requirements, the Panel's Market Surveillance Unit can be contacted at +44 (0)20 7638 0129.

This disclosure provides transparency about the trading activities of Singer Capital Markets Securities Ltd in relation to HIPGNOSIS SONGS FUND LTD's securities, ensuring compliance with regulatory requirements and promoting market integrity.